Yan Wang, Ph.D. (she/her/hers)

Staff Fellow
US Food and Drug Administration

Poster(s):

• (W1030-02-08) Characterization of In Situ Forming Implants Using CT Imaging
  Wednesday, October 25, 2023

  10:30 AM – 11:30 AM ET

• (T1430-09-62) Characterization of Intravenous Iron Supplements: Injectafer^®
  Tuesday, October 24, 2023

  2:30 PM – 3:30 PM ET

• (M1030-11-76) Correlation between Material Properties, Extrusion Processing Conditions and Permeability of Etonogestrel in Polyethylene Vinyl Acetate Films
  Monday, October 23, 2023

  10:30 AM – 11:30 AM ET

• (M1530-09-58) Critical Manufacturing Parameters and Their Impacts on the Product Attributes of Bupivacaine Multivesicular Liposomal Formulation (Exparel^®)
  Monday, October 23, 2023

  3:30 PM – 4:30 PM ET

• (T1530-09-61) Effect of Collagen Source on the In Vitro Performance of Collagen Implant
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET

• (M1130-08-52) Enabling Formulation Development of LAIs Thorough Understanding Critical Formulation Parameters
  Monday, October 23, 2023

  11:30 AM – 12:30 PM ET

• (T1530-11-73) Investigating the Relationship between Microstructural Properties and In Vitro Release Characteristics of PLGA Microspheres
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET

• (M1030-11-73) Manufacturing and Elucidating the Drug Release Mechanisms of Long-Acting Ethylene Vinyl Acetate-Based Implants
  Monday, October 23, 2023

  10:30 AM – 11:30 AM ET

• (W1130-12-82) Mechanistic Modeling of Intramuscular Administration of Long-Acting Injectable Suspensions Accounting for Fibrosis at the Depot Site
  Wednesday, October 25, 2023

  11:30 AM – 12:30 PM ET

• (T1530-12-78) Preclinical Evaluation of Brinzolamide Ophthalmic Suspensions with Variations in Critical Quality Attributes and Considerations for Pharmacokinetic/Pharmacodynamic Study Designs
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET

• (T0930-11-75) Role of PLGA Variability in Controlled Drug Release from Dexamethasone Intravitreal Implants
  Tuesday, October 24, 2023

  9:30 AM – 10:30 AM ET

• (T1330-08-50) Tailoring Drug Release from Long-Acting Contraceptive Levonorgestrel-Containing Intrauterine Systems
  Tuesday, October 24, 2023

  1:30 PM – 2:30 PM ET

• (M1330-08-55) Understanding Release Mechanism and Development of Accelerated Release Tests for Long-Term Intrauterine Systems
  Monday, October 23, 2023

  1:30 PM – 2:30 PM ET

• (M1430-11-76) Understanding the Impact of Accelerated Release Testing Conditions on Transport Properties and Release Mechanisms of Drug from Long-Acting Ethylene Vinyl Acetate Implants
  Monday, October 23, 2023

  2:30 PM – 3:30 PM ET